192 related articles for article (PubMed ID: 29606285)
1. Predictors of early, intermediate and late biochemical recurrence after minimally invasive radical prostatectomy in a single-centre cohort with a mean follow-up of 8 years.
García-Barreras S; Nunes I; Srougi V; Secin F; Baghdadi M; Sánchez-Salas R; Barret E; Rozet F; Galiano M; Cathelineau X
Actas Urol Esp (Engl Ed); 2018 Oct; 42(8):516-523. PubMed ID: 29606285
[TBL] [Abstract][Full Text] [Related]
2. The Role of Prostate-specific Antigen Persistence After Radical Prostatectomy for the Prediction of Clinical Progression and Cancer-specific Mortality in Node-positive Prostate Cancer Patients.
Bianchi L; Nini A; Bianchi M; Gandaglia G; Fossati N; Suardi N; Moschini M; Dell'Oglio P; Schiavina R; Montorsi F; Briganti A
Eur Urol; 2016 Jun; 69(6):1142-8. PubMed ID: 26749093
[TBL] [Abstract][Full Text] [Related]
3. Predictors of biochemical recurrence after Retzius-sparing robot-assisted radical prostatectomy: Analysis of 359 cases with a median follow-up period of 26 months.
Abdel Raheem A; Chang KD; Alenzi MJ; Ham WS; Han WK; Choi YD; Rha KH
Int J Urol; 2018 Dec; 25(12):1006-1014. PubMed ID: 30276864
[TBL] [Abstract][Full Text] [Related]
4. Predictive factors and oncological outcomes of persistently elevated prostate-specific antigen in patients following robot-assisted radical prostatectomy.
Kumar A; Samavedi S; Mouraviev V; Bates AS; Coelho RF; Rocco B; Patel VR
J Robot Surg; 2017 Mar; 11(1):37-45. PubMed ID: 27245233
[TBL] [Abstract][Full Text] [Related]
5. Impact of positive surgical margins on prostate-specific antigen failure after radical prostatectomy in adjuvant treatment-naïve patients.
Ploussard G; Agamy MA; Alenda O; Allory Y; Mouracade P; Vordos D; Hoznek A; Abbou CC; de la Taille A; Salomon L
BJU Int; 2011 Jun; 107(11):1748-54. PubMed ID: 20883488
[TBL] [Abstract][Full Text] [Related]
6. Biochemical recurrence-free conditional probability after radical prostatectomy: A dynamic prognosis.
García-Barreras S; Sanchez-Salas R; Mejia-Monasterio C; Muttin F; Secin F; Dell'Oglio P; Nunes-Silva I; Srougi V; Barret E; Rozet F; Prapotnich D; Cathelineau X
Int J Urol; 2019 Jul; 26(7):725-730. PubMed ID: 31001870
[TBL] [Abstract][Full Text] [Related]
7. Prostate cancer biochemical recurrence rates after robotic-assisted laparoscopic radical prostatectomy.
Ginzburg S; Nevers T; Staff I; Tortora J; Champagne A; Kesler SS; Laudone VP; Wagner JR
JSLS; 2012; 16(3):443-50. PubMed ID: 23318071
[TBL] [Abstract][Full Text] [Related]
8. Positive surgical margins and biochemical recurrence following minimally-invasive radical prostatectomy - An analysis of outcomes from a UK tertiary referral centre.
Sachdeva A; Veeratterapillay R; Voysey A; Kelly K; Johnson MI; Aning J; Soomro NA
BMC Urol; 2017 Oct; 17(1):91. PubMed ID: 28969608
[TBL] [Abstract][Full Text] [Related]
9. Extent of positive surgical margins following radical prostatectomy: impact on biochemical recurrence with long-term follow-up.
Koskas Y; Lannes F; Branger N; Giusiano S; Guibert N; Pignot G; Walz J; Rossi D; Bastide C
BMC Urol; 2019 May; 19(1):37. PubMed ID: 31092240
[TBL] [Abstract][Full Text] [Related]
10. Prediction of biochemical recurrence after radical prostatectomy. New tool for selecting candidates for adjuvant radiation therapy.
Herranz-Amo F; Molina-Escudero R; Ogaya-Pinies G; Ramírez-Martín D; Verdú-Tartajo F; Hernández-Fernández C
Actas Urol Esp; 2016 Mar; 40(2):82-7. PubMed ID: 26424411
[TBL] [Abstract][Full Text] [Related]
11. Oncologic outcomes after minimally invasive radical prostatectomy in patients with seminal vesicle invasion (pT3b) without adjuvant therapy.
Forgues A; Rozet F; Audenet F; Ouzzane A; Sanchez-Salas R; Barret E; Galiano M; Prapotnich D; Cathelineau X
World J Urol; 2014 Apr; 32(2):519-24. PubMed ID: 23881352
[TBL] [Abstract][Full Text] [Related]
12. [Long term biochemical recurrence free survival after radical prostatectomy for cancer: comparative analysis according to surgical approach and clinicopathological stage].
Rizk J; Ouzzane A; Flamand V; Fantoni JC; Puech P; Leroy X; Villers A
Prog Urol; 2015 Mar; 25(3):157-68. PubMed ID: 25614075
[TBL] [Abstract][Full Text] [Related]
13. Stage T1-2 prostate cancer: a multivariate analysis of factors affecting biochemical and clinical failures after radical prostatectomy.
Kupelian PA; Katcher J; Levin HS; Klein EA
Int J Radiat Oncol Biol Phys; 1997 Mar; 37(5):1043-52. PubMed ID: 9169811
[TBL] [Abstract][Full Text] [Related]
14. Risk of biochemical recurrence based on extent and location of positive surgical margins after robot-assisted laparoscopic radical prostatectomy.
Marcq G; Michelet A; Hannink G; Rizk J; Sauvain J; Villers A; Saffarini M; Rochat CH
BMC Cancer; 2018 Dec; 18(1):1291. PubMed ID: 30587172
[TBL] [Abstract][Full Text] [Related]
15. Pathological and 3 Tesla Volumetric Magnetic Resonance Imaging Predictors of Biochemical Recurrence after Robotic Assisted Radical Prostatectomy: Correlation with Whole Mount Histopathology.
Tan N; Shen L; Khoshnoodi P; Alcalá HE; Yu W; Hsu W; Reiter RE; Lu DY; Raman SS
J Urol; 2018 May; 199(5):1218-1223. PubMed ID: 29128577
[TBL] [Abstract][Full Text] [Related]
16. Survival analysis of patients with prostate cancer and unfavorable risk factors treated with radical prostatectomy and salvage radiotherapy after biochemical recurrence and persistence.
Barbas Bernardos G; Herranz Amo F; González San Segundo C; Caño Velasco J; Subirá Ríos D; Moralejo Gárate M; Mayor de Castro J; Aragón Chamizo J; Hernández Fernández C
Actas Urol Esp (Engl Ed); 2020 Dec; 44(10):701-707. PubMed ID: 32595092
[TBL] [Abstract][Full Text] [Related]
17. Predictive factors for short-term biochemical recurrence-free survival after robot-assisted laparoscopic radical prostatectomy in high-risk prostate cancer patients.
Kanehira M; Takata R; Ishii S; Ito A; Ikarashi D; Matsuura T; Kato Y; Obara W
Int J Clin Oncol; 2019 Sep; 24(9):1099-1104. PubMed ID: 30972506
[TBL] [Abstract][Full Text] [Related]
18. Comparison between laparoscopic and open prostatectomy: Oncological progression analysis.
Martínez-Holguín E; Herranz-Amo F; Mayor de Castro J; Polanco-Pujol L; Hernández-Cavieres J; Subirá-Ríos D; Moralejo-Gárate MI; Aragón-Chamizo J; Hernández-Fernández C
Actas Urol Esp (Engl Ed); 2021 Mar; 45(2):139-145. PubMed ID: 33160757
[TBL] [Abstract][Full Text] [Related]
19. PSA doubling time as a predictor of clinical progression after biochemical failure following radical prostatectomy for prostate cancer.
Roberts SG; Blute ML; Bergstralh EJ; Slezak JM; Zincke H
Mayo Clin Proc; 2001 Jun; 76(6):576-81. PubMed ID: 11393495
[TBL] [Abstract][Full Text] [Related]
20. Targeted salvage lymphadenectomy in patients treated with radical prostatectomy with biochemical recurrence: complete biochemical response without adjuvant therapy in patients with low volume lymph node recurrence over a long-term follow-up.
Winter A; Henke RP; Wawroschek F
BMC Urol; 2015 Feb; 15(1):10. PubMed ID: 25881245
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
